Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 209

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

Zhu, Saijie, Hong, Minghuang, Zhang, Lihong, Tang, Guotao, Jiang, Yanyan, Pei, Yuanying·2010·Pharmaceutical Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11095-009-9992-1

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 48

  1. Khandare J, Minko T. Polymer–drug conjugates: progress in polymeric prodrugs. Prog Polym Sci. 2006;31:359–97. · DOI · Paper page
  2. Patri AK, Majoros I, Baker JR Jr. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol. 2002;6:466–71. · DOI · Paper page
  3. Majoros IJ, Thomas TP, Mehta CB, Baker JR Jr. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem. 2005;48:5892–9. · DOI · Paper page
  4. Patri AK, Myc A, Beals J, Thomas TP, Bander NH, Baker JR Jr. Synthesis and in vitro testing of J591 antibody−dendrimer conjugates for targeted prostate cancer therapy. Bioconjugate Chem. 2004;15:1174–81. · DOI · Paper page
  5. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Control Release. 2000;65:133–48. · DOI · Paper page
  6. Calabretta MK, Kumar A, McDermott AM, Cai C. Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups. Biomacromolecules. 2007;8:1807–11. · DOI · Paper page
  7. Luo D, Haverstick K, Belcheva N, Han E, Saltzman WM. Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery. Macromolecules. 2002;35:3456–62. · DOI · Paper page
  8. Kratz F, Beyer U, Schutte MT. Drug-polymer conjugates containing acid-cleavable bonds. Crit Rev Ther Drug Carrier Syst. 1999;16:245–88. · DOI · Paper page
  9. Shen WT, Ryser HJP. Cis-aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem Biophys Res Commun. 1981;102:1048–54. · DOI · Paper page
  10. Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. J Control Release. 2003;87:33–47. · DOI · Paper page
  11. Kakinoki A, Kaneo Y, Ikeda Y, Tanaka T, Fujita K. Synthesis of poly(vinyl alcohol)-doxorubicin conjugates containing cis-aconityl acid-cleavable bond and its isomer dependent doxorubicin release. Biol Pharm Bull. 2008;31:103–10. · DOI
  12. Yoo HS, Lee EA, Park TG. Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J Control Release. 2002;82:17–27. · DOI · Paper page
  13. Zhu Z, Kralovec J, Ghose T, Mammen M. Inhibition of Epstein-Barr-virus-transformed human chronic lymphocytic leukaemic B cells with monoclonal-antibody-Adriamycin (doxorubicin) conjugates. Cancer Immunol Immunother. 1995;40:257–67.
  14. Bender ML. General acid-base catalysis in the intramolecular hydrolysis of phthalamic acid. J Am Chem Soc. 1957;79:1258–9. · doi:10.1021/ja01562a059
  15. Hudecz F, Ross H, Price MR, Baldwin RW. Immunoconjugate design: a predictive approach for coupling of daunomycin to monoclonal antibodies. Bioconjugate Chem. 1990;1:197–204. · doi:10.1021/bc00003a004
  16. Luo Y, Bernshaw NJ, Lu ZR, Kopecek J, Prestwich GD. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res. 2002;19:396–402. · DOI · Paper page
  17. Saovapakhiran A, D’Emanuele A, Attwood D, Penny J. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization. Bioconjugate Chem. 2009;20:693–701. · doi:10.1021/bc8002343
  18. Tomlinson R, Heller J, Brocchini S, Duncan R. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjugate Chem. 2003;14:1096–106. · DOI
  19. Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Boucek J. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. J Control Release. 2008;127:121–30. · DOI
  20. Yoshimoto M, Ogawa K, Washiyama K, Shikano N, Mori H, Amano R. Alpha(v)beta(3) integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide. Int J Cancer. 2008;123:709–15. · doi:10.1002/ijc.23575
  21. Greco F, Vicent MJ, Gee S, Jones AT, Gee J, Nicholson RI. Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. J Control Release. 2007;117:28–39. · DOI
  22. Raucher D, Chilkoti A. Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition. Cancer Res. 2001;61:7163–70.
  23. Massodi I, Bidwell GL III, Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release. 2005;108:396–408. · DOI · Paper page
  24. Liu J, Shapiro JI. Endocytosis and signal transduction: basic science update. Biol Res Nurs. 2003;5:117–28. · DOI
  25. Hed J, Hallden G, Johansson SG, Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods. 1987;101:119–25. · DOI · Paper page
  26. Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol. 1989;108:389–400. · DOI · Paper page
  27. Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res. 2006;66:11878–87. · DOI · Paper page
  28. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolar-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of selected macromolecules. J Cell Biol. 1994;127:1217–32. · DOI · Paper page
  29. Kansara V, Paturi D, Luo S, Gaudana R, Mitra AK. Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells. Int J Pharm. 2008;355:210–9. · DOI
  30. Krogstad DJ, Schlesinger PH. The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. Am J Trop Med Hyg. 1987;36:213–20. · DOI
  31. Yang HM, Reisfeld RA. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proc Natl Acad Sci U S A. 1988;85:1189–93. · DOI
  32. Lee SJ, Park K, Oh YK, Kwon SH, Her S, Kim IS. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials. 2009;30:2929–39. · DOI · Paper page
  33. Blum RH, Carter SH. Adriamycin: a new anticancer drug with significant clinical activity. Ann Intern Med. 1974;80:249–59. · DOI · Paper page
  34. Sadzuka Y, Nakade A, Hirama R, Miyagishima A, Nozawa Y, Hirota S. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int J Pharm. 2002;238:171–80. · DOI
  35. Glodde M, Sirsi SR, Lutz GJ. Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides. Biomacromolecules. 2006;7:347–56. · DOI
  36. Majoros IJ, Keszler B, Woehler S, Bull T, Baker JR Jr. Acetylation of poly(amidoamine) dendrimers. Macromolecules. 2003;36:5526–9. · DOI · Paper page
  37. Papagiannaros A, Dimas K, Papaioannou GT, Demetzos C. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. Int J Pharm. 2005;302:29–38. · DOI
  38. Ke W, Zhao Y, Huang R, Jiang C, Pei Y. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J Pharm Sci. 2008;97:2208–16. · DOI · Paper page
  39. Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H. Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res. 2007;24:2138–45. · DOI · Paper page
  40. Kitchens KM, Kolhatkar RB, Swaan PW, Ghandehari H. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol Pharm. 2008;5:364–9. · DOI
  41. Seib FP, Jones AT, Duncan R. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Control Release. 2007;117:291–300. · DOI · Paper page
  42. Saovapakhiran A, D’Emanuele A, Attwood D, Penny J. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization. Bioconjugate Chem. 2009;20:693–701. · doi:10.1021/bc8002343
  43. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol. 2001;3:473–83. · DOI · Paper page
  44. Hamasaki M, Araki N, Hatae T. Association of early endosomal autoantigen 1 with macropinocytosis in EGF-stimulated A431 cells. Anat Rec A Discov Mol Cell Evol Biol. 2004;277:298–306. · DOI
  45. Owens DE III, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93–102. · DOI · Paper page
  46. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999;57:727–34. · DOI · Paper page
  47. Malugin A, Kopecková P, Kopecek J. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. J Control Release. 2007;124:6–10. · DOI
  48. Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 2005;76:1439–53. · DOI · Paper page

Cited by

See all 209

Metadata

Authors
Zhu, S., Hong, M., Zhang, L., Tang, G., Jiang, Y., & Pei, Y.
Venue
Pharmaceutical Research
Published
2009-10-28
Volume
27
Issue
1
Pages
161-174
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W1983979770
Cited by
209
References
1
FWCI
11.15
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation. https://app.cochat.ai/papers/10.1007/s11095-009-9992-1
The paper
Zhu, S., Hong, M., Zhang, L., Tang, G., Jiang, Y., & Pei, Y. (2010). PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation. Pharmaceutical Research. https://doi.org/10.1007/s11095-009-9992-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.